A shadow market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.
Some experts said the popularity for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.
Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, risking fines, prosecution or prison.
Platform Response and Material Removal
According to the social media company, the platform has taken down problematic material and prohibited related keywords and search suggestions. The company said it was dedicated to maintaining the service secure and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Investigations also found communities with up to 9,000 members selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of members, populated with photos of slimming results, glowing reviews and step-by-step guides for mixing or injecting at home.
Within moments of entering one group, a seller shared WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, health issues or previous experience.
Product Information and Pricing
Inside these communities, messages display dark colored parcels with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for Telegram stated it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they can’t verify. Even if the research behind this drug is sound, these online products may not include what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has already seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to possibly serious health risks”.
